Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension of RECOVER
2006-006907-35Phase 3Terminated
- Sponsor
- Schwarz Pharma
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of rotigotine in Parkinson's disease (PD), sponsored by Schwarz Pharma. Primary endpoint: Change from baseline in UPDRS Part II score. Started Jan 2007; status: terminated.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-006907-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006907-35.